Larimar Therapeutics Inc (LRMR)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Carole S. Ben-Maimon |
| Employees: | 30 |
| Web site: | larimartx.com |
|
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
844-511-9056
| |
| Date | Ratio |
|---|---|
| 2020-05-29 | 1:12 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia.
Please log in first to see chart